In reply to AP ...> Bioshares , as far as they were concerned, POH's reporting of their science was weak, that it lacked the sort of validation rigour that would make POH's reports convincing, that there were more questions raised than answered.
As a disclosure: I subscribe to a number of paid reports and I have made some $ by ignoring quite a few of Bioshares recommendations and in some cases doing quite the opposite to their buy/sells/hold/avoid.
board clear out - on way, page-32
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 24963227 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 32141413 | 19 |
View Market Depth
| Last trade - 16.12pm 17/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable